Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Gaia Sampogna, Filippo Caraci, Claudia Carmassi, Bernardo Dell’Osso, Silvia Ferrari, Giovanni Martinotti, Gabriele Sani, Gianluca Serafini, Maria Salvina Signorelli & Andrea Fiorillo. (2023) Efficacy and tolerability of desvenlafaxine in the real-world treatment of patients with major depression: a narrative review and an expert opinion paper. Expert Opinion on Pharmacotherapy 24:14, pages 1511-1525.
Read now
Read now
Trevor R Norman & James S Olver. (2021) Desvenlafaxine in the treatment of major depression: an updated overview. Expert Opinion on Pharmacotherapy 22:9, pages 1087-1097.
Read now
Read now
Wei Zhou, Shuang-long Li, Ti Zhao, Le Li, Wen-bin Xing, Xiang-jun Qiu & Wei Zhang. (2020) Effects of Dexmedetomidine on the Pharmacokinetics of Dezocine, Midazolam and Its Metabolite 1-Hydroxymidazolam in Beagles by UPLC-MS/MS. Drug Design, Development and Therapy 14, pages 2595-2605.
Read now
Read now
Articles from other publishers (22)
Hannah E. Cook, Jennie H. Hewitt, Emily P. Patterson & Amy E. Randolph. (2022) Impact of Drug Interactions on Major Bleed Rates in Patients Taking Direct Oral Anticoagulants. Journal of Pharmacy Practice 36:3, pages 600-605.
Crossref
Crossref
Ebuwa Igho-Osagie, Kaylen Brzozowski, Harry Jin, Jeffrey Brown, Marissa Grifasi Williams & Amy Puenpatom. (2023) Prevalence of Potential Drug-Drug Interactions With Ritonavir-Containing COVID-19 Therapy in the United States: An Analysis of the National Health and Nutrition Examination Survey. Clinical Therapeutics.
Crossref
Crossref
Cvetka Bačar Bole, Katja Nagode, Mitja Pišlar, Aleš Mrhar, Iztok Grabnar & Tomaž Vovk. (2023) Potential Drug-Drug Interactions among Patients with Schizophrenia Spectrum Disorders: Prevalence, Association with Risk Factors, and Replicate Analysis in 2021. Medicina 59:2, pages 284.
Crossref
Crossref
Yang Chen & Lijun Ding. (2023) Potential drug-drug interactions in outpatients with depression of a psychiatry department. Saudi Pharmaceutical Journal 31:2, pages 207-213.
Crossref
Crossref
Natalie K. Kolba, Byungho Lee, Henry J. Tannous, Thomas V. Bilfinger & Annie L. Shroyer. (2022) Preoperative mental illness and postoperative atrial fibrillation in cardiac surgery patients: Identifying a vulnerable population. Journal of Clinical and Translational Science 7:1.
Crossref
Crossref
Katarzyna Stachowicz & Magdalena Sowa-Kućma. (2022) The treatment of depression — searching for new ideas. Frontiers in Pharmacology 13.
Crossref
Crossref
Sai Dheeraj Gutlapalli, Vamsi Krishna Lavu, Rana Abdelwahab Mohamed, Ruimin Huang, Shanthi Potla, Sushen Bhalla, Yousif Al Qabandi, Savitri Aninditha Nandula, Chinmayi Sree Boddepalli & Pousette Hamid. (2022) The Risk of Fatal Arrhythmias in Post-Myocardial Infarction Depression in Association With Venlafaxine. Cureus.
Crossref
Crossref
Mohamed H. Al-Sabri, Maryam Nikpour, Laura E. Clemensson, Misty M. Attwood, Michael J. Williams, Mathias Rask-Anderson, Jessica Mwinyi & Helgi B. Schiöth. (2022) The regulatory role of AP-2β in monoaminergic neurotransmitter systems: insights on its signalling pathway, linked disorders and theragnostic potential. Cell & Bioscience 12:1.
Crossref
Crossref
Sungwon Roh, Kang Soo Lee, Songhwa Choi & Jae-Min Kim. (2022) Safety and Effectiveness of Desvenlafaxine in Korean Patients with Major Depressive Disorder: A 6-month Postmarketing Surveillance Study. Clinical Psychopharmacology and Neuroscience 20:3, pages 548-559.
Crossref
Crossref
Zohaib Akhter, Olamide Todowede, Jennifer Valeska Elli Brown, Alexander Jarde, Laraib Mazhar, Venkata lakshmi narasimha, Sagir Muhammad, Sheraz Fazid, Khalid Rehman, Chetana Deshmukh, Akeemat Ayinla, Funmilola Wuraola, Mir Nabila Ashraf & Najma Siddiqi. (2022) Pharmacological interventions for depression in adults with chronic hepatitis B or C. Cochrane Database of Systematic Reviews 2022:8.
Crossref
Crossref
Caren Nádia Soares de Sousa, Ingridy da Silva Medeiros, Germana Silva Vasconcelos, Gabriel Angelo de Aquino, Francisco Maurício Sales Cysne Filho, Jamily Cunha de Almeida Cysne, Danielle Silveira Macêdo & Silvânia Maria Mendes Vasconcelos. (2022) Involvement of oxidative pathways and BDNF in the antidepressant effect of carvedilol in a depression model induced by chronic unpredictable stress. Psychopharmacology 239:1, pages 297-311.
Crossref
Crossref
Narcís Cardoner, Antoni Sicras-Mainar, Javier Rejas & Beatriz Armada. (2021) Adherence to Desvenlafaxine Versus Usual Care and Its Impact on Health Outcomes: A Comparative Real-world Clinical Study. Clinical Drug Investigation 41:12, pages 1055-1066.
Crossref
Crossref
Mouza S.R Al Zaabi, Sathvik Belagodu Sridhar, Talaat Matar Tadross & Atiqulla Shariff. (2021) Frequency and Predictors of Potential Drug Interactions among Psychiatry Outpatients on Treatment with Antidepressant Medications. Biomedical and Pharmacology Journal 14:3, pages 1209-1218.
Crossref
Crossref
Kelly Bleasby, Robert Houle, Michael Hafey, Meihong Lin, Jingjing Guo, Bing Lu, Rosa I. Sanchez & Kerry L. Fillgrove. (2021) Islatravir Is Not Expected to Be a Victim or Perpetrator of Drug-Drug Interactions via Major Drug-Metabolizing Enzymes or Transporters. Viruses 13:8, pages 1566.
Crossref
Crossref
Fernando Barata, Carlos Aguiar, Tiago Reis Marques, José Bravo Marques & Venceslau Hespanhol. (2021) Monitoring and Managing Lorlatinib Adverse Events in the Portuguese Clinical Setting: A Position Paper. Drug Safety 44:8, pages 825-834.
Crossref
Crossref
Yaser Pashaei. (2021) Drug repurposing of selective serotonin reuptake inhibitors: Could these drugs help fight COVID-19 and save lives?. Journal of Clinical Neuroscience 88, pages 163-172.
Crossref
Crossref
Kristina Konstantinovna Khacheva, Gulnara Rinatovna Khakimova, Alexey Borisovich Glazunov & Victoria Vyacheslavovna Fateeva. 2021. Anxiety Disorders - The New Achievements. Anxiety Disorders - The New Achievements.
Demetra Antimisiaris, Brittany McHolan, Daniela Moga & Cortney Mospan. (2021) Medication Related Problems. The Senior Care Pharmacist 36:2, pages 68-82.
Crossref
Crossref
Emily E. Bay. 2021. Absolute Geriatric Psychiatry Review. Absolute Geriatric Psychiatry Review
213
228
.
Abhishek Chakladar, Jawahar Singh, Nand Kishor Tak, Bichitra Nanda Patra & Rajesh Sagar. (2020) Fluvoxamine-Associated Galactorrhea. Journal of Clinical Psychopharmacology 40:1, pages 101-102.
Crossref
Crossref
SethW Perry, Julio Licinio & Ma-Li Wong. (2019) The depressed heart. Heart and Mind 3:2, pages 35.
Crossref
Crossref
Piotr Boguta, Dariusz Juchnowicz, Paulina Wróbel-Knybel, Agnieszka Biała-Kędra & Hanna Karakuła-Juchnowicz. (2018) Safety of concomitant treatment with Non-Vitamin K Oral Anticoagulants and SSRI/SNRI antidepressants. Current Problems of Psychiatry 19:4, pages 267-278.
Crossref
Crossref